Related Experiment Videos
Conversion from low grade to high grade of rat urinary bladder carcinomas
1Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611.
Cancer Research
|March 1, 1988
Summary
A second dose of N-methyl-Nitrosourea (MNU) can transform low-grade rat bladder carcinomas into high-grade, invasive cancers. This suggests additional carcinogen exposure can drive tumor progression by inducing new mutations.
Area of Science:
- Oncology
- Carcinogenesis
- Experimental Pathology
Background:
- N-methyl-Nitrosourea (MNU) is a known carcinogen used to induce tumors in experimental models.
- Understanding the progression of induced tumors is crucial for developing effective cancer treatments.
Purpose of the Study:
- To investigate if a second dose of MNU can convert low-grade induced carcinomas into high-grade, invasive carcinomas.
- To determine the effect of delayed carcinogen exposure on tumor progression in a rat bladder model.
Main Methods:
- Heterotopically transplanted rat urinary bladders were used in male Fischer 344 rats.
- Rats received an initial dose of MNU or saline (control) at 4 weeks post-transplantation.
- A subset of animals received a second MNU or saline dose at week 29, with all animals observed until week 50.
Main Results:
- MNU-induced carcinomas at week 29 were consistently low-grade and non-invasive.
- A second MNU dose at week 29 significantly increased the incidence of high-grade, invasive carcinomas (P < 0.01).
- Tumor incidence and multiplicity increased with longer follow-up without a second MNU dose, but high-grade tumors remained rare.
Conclusions:
- A second administration of MNU can induce new mutations in existing low-grade carcinomas, leading to the development of invasive, high-grade tumors.
- This study supports the hypothesis that sequential carcinogen exposure can drive tumor dedifferentiation and invasiveness.